Oct 10 (Reuters) - Olema Pharmaceuticals Inc OLMA.O :
* OLEMA ONCOLOGY ANNOUNCES EXPANSION OF COLLABORATION
AGREEMENT
WITH NOVARTIS
* OLEMA ONCOLOGY ANNOUNCES EXPANSION OF COLLABORATION
AGREEMENT
WITH NOVARTIS
* OLEMA PHARMACEUTICALS INC - AMENDMENT TO EXISTING CLINICAL
COLLABORATION AND SUPPLY AGREEMENT WITH NOVARTIS INSTITUTES FOR
BIOMEDICAL RESEARCH, INC.
* OLEMA PHARMACEUTICALS: AMENDMENT TO INCREASE ONGOING PHASE
1/2
CLINICAL STUDY SIZE TO ABOUT 60 PATIENTS
* OLEMA PHARMACEUTICALS: EXPANDED STUDY HAS POTENTIAL TO
GENERATE
CLINICAL DATASET SUFFICIENT TO SUPPORT REGULATORY PATHWAY FOR
FIRST-LINE PIVOTAL TRIAL
Source text for Eikon: ID:nGNX7DZG6x
Further company coverage: OLMA.O
((Reuters.Briefs@thomsonreuters.com;))